Clinical trial
A Multicenter, Prospective Trial Evaluating the Safety and Efficacy of the Implantable Artificial Bronchus (IAB) in Adults Suffering From Severe Emphysema
NCT07119229 is registered in ClinicalTrials.gov with Pulmair Medical, Inc. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Multicenter, Prospective Trial Evaluating the Safety and Efficacy of the Implantable Artificial Bronchus (IAB) in Adults Suffering From Severe Emphysema
- Lead sponsor
- Pulmair Medical, Inc.
- Phase
- Not applicable
- Overall status
- Recruiting
- Start date
- March 25, 2026
- Completion date
- November 30, 2027
- Enrollment
- 60 (estimated)
- Sites
- 4
Conditions
As the registry lists them; a condition with its own page is linked.
copd, emphysema, emphysema or copd